Analyst firms · Robert W. Baird · VOR
Robert W. Baird VOR price target and rating history
Vor Biopharma Inc. (VOR) · Health Care
Robert W. Baird rates Vor Biopharma Inc. (VOR) Outperform with a $64 price target, as of its latest action on Oct 15, 2025. It has published 3 rating actions on VOR since December 2021, including 1 upgrade and 0 downgrades. Across 4 firms with a VOR price target in the last 12 months, the median target is $40.
- Current rating
- Outperform
- Price target
- $64
- Median target, all firms
- $40
- Actions on VOR
- 3
Robert W. Baird price target on VOR
Every Robert W. Baird rating on VOR
- Oct 15, 2025
- Dec 3, 2021
- Dec 3, 2021
How other firms rate VOR
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| William Blair | Outperform | Oct 21, 2026 | |
| Jefferies | Buy | $50 | Mar 30, 2026 |
| Wells Fargo | Overweight | $30 | Mar 19, 2026 |
| Citigroup | Buy | $50 | Jan 9, 2026 |
| TD Cowen | Buy | Dec 17, 2025 | |
| Wedbush | Neutral | $9 | Nov 25, 2025 |
Questions about Robert W. Baird and VOR
- What is Robert W. Baird's price target for VOR?
- Robert W. Baird's latest stated price target for Vor Biopharma Inc. (VOR) is $64, from its action on Oct 15, 2025.
- What is Robert W. Baird's rating on VOR?
- Robert W. Baird rates VOR Outperform, a bullish rating, as of Oct 15, 2025.
- When did Robert W. Baird last change its view on VOR?
- On Oct 15, 2025, Robert W. Baird upgrades to Outperform from Neutral, price target $64.
- How does Robert W. Baird's VOR target compare with other analysts?
- Across 4 firms with a VOR price target in the last 12 months, the median target is $40.
All Robert W. Baird ratingsVOR news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.